William S. Harris, (also known as Bill Harris) PhD FAHA FASN is an American professor and researcher focusing on human nutrition. His work has focused on the role of Omega-3 fatty acids as they relate to cardiovascular disease and neuropsychiatric disease.[1][2][3][4]
Bill Harris PhD, FAHA | |
---|---|
Born | William S. Harris |
Alma mater | University of Minnesota |
Occupation | Human Nutrition Researcher |
Known for | Omega-3 Fatty Acid research |
Website | Profile on OmegaQuant.com |
Education and academic career
editA 1971 graduate of Hanover College where he majored in chemistry,[5] Harris completed a PhD in Nutrition and Food Science from the University of Minnesota in 1978[6] He was a Professor of Medicine at the University of Missouri-Kansas City, where he was the Daniel J. Lauer/Missouri Chair in Lipid Metabolism until 2006.[4][7] He co-directed the Lipid and Diabetes Research Center at the Mid America Heart Institute of Saint Luke's Hospital of Kansas City.[4] In 2006, he joined faculty at the University of South Dakota Sanford School of Medicine, where he directed the Cardiovascular Health Research Center at the Sanford Research Center.[6]
Industry career
editHarris founded OmegaQuant in 2009 to develop the RBC omega-3 index as a research assay.[6] This assay was later acquired by the Health Diagnostic Laboratory.[4]
Research
editHis work focused on the role of lipid and lipoprotein metabolism in human disease,[8] and specifically the development of an RBC omega-3 index.[1][2][3] In 2009, he chaired an American Heart Association science advisory on Omega-6 fatty acids and cardiovascular disease.[9] He has authored >300 manuscripts in peer-reviewed literature.[10]
Honors and awards
editHarris is a Fellow of the American Heart Association and a Fellow of the American Society for Nutrition.[11]
References
edit- ^ a b Tan ZS, Harris WS, Beiser AS, Au R, Himali JJ, Debette S, Pikula A, Decarli C, Wolf PA, Vasan RS, Robins SJ, Seshadri S (February 2012). "Red blood cell ω-3 fatty acid levels and markers of accelerated brain aging". Neurology. 78 (9): 658–64. doi:10.1212/WNL.0b013e318249f6a9. PMC 3286229. PMID 22371413.
- ^ a b Shearer GC, Pottala JV, Spertus JA, Harris WS (2009). "Red blood cell fatty acid patterns and acute coronary syndrome". PLOS ONE. 4 (5): e5444. Bibcode:2009PLoSO...4.5444S. doi:10.1371/journal.pone.0005444. PMC 2673680. PMID 19421317.
- ^ a b Kris-Etherton PM, Harris WS, Appel LJ (November 2002). "Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease". Circulation. 106 (21): 2747–57. doi:10.1161/01.cir.0000038493.65177.94. PMID 12438303.
- ^ a b c d William S. Harris, PhD Biography hosted at cim.med.miami.edu. Accessed 2021-09-01.
- ^ "William S. Harris". ORCID. Retrieved 2022-08-24.
- ^ a b c Passwater, Richard A (21 November 2019). "Updated Suggestions for Omega Balanced Fatty Acids and Exciting New Fish Oil Studies". Whole Foods Magazine. Retrieved 21 September 2021.
- ^ Harris, William S. "The COMBination of Prescription Omega-3 With Simvastatin (COMBOS) Study: An Expert Interview With William S. Harris, PhD". Medscape. Retrieved 1 September 2021.
- ^ Harris WS (June 1989). "Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review". J Lipid Res. 30 (6): 785–807. doi:10.1016/S0022-2275(20)38310-3. PMID 2677200.
- ^ Harris WS, Mozaffarian D, Rimm E, Kris-Etherton P, Rudel LL, Appel LJ; et al. (2009). "Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention". Circulation. 119 (6): 902–7. doi:10.1161/CIRCULATIONAHA.108.191627. PMID 19171857. S2CID 15072227.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ PubMed index of William S. Harris. Accessed 01 Sept 2021.
- ^ ASN Staff (13 May 2020). "The American Society for Nutrition Foundation Announces Class of 2020 Fellows". American Society for Nutrition. Retrieved 1 September 2021.